ERX Pharmaceuticals Inc. focuses on a recent knowledge of science of obesity.
ERX Pharmaceuticals has raised $6.0M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2025.
ERX Pharmaceuticals is headquartered in Cambridge, United States.
ERX Pharmaceuticals Inc. focuses on a recent knowledge of science of obesity.
ERX Pharmaceuticals is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ERX Pharmaceuticals — Funding & Investors." VCBacked, December 15, 2025, https://www.vcbacked.co/company/erx-pharmaceuticals. Accessed November 13, 2026.
VCBacked. (2025). ERX Pharmaceuticals — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/erx-pharmaceuticals
{{cite web |title=ERX Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/erx-pharmaceuticals |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ERX Pharmaceuticals? Request a listing update